Editorial: Circulating molecular biomarkers: next-generation tools for monitoring minimal residual disease in cancer patients

Front Oncol. 2023 Jul 24:13:1226974. doi: 10.3389/fonc.2023.1226974. eCollection 2023.

Authors

Zohreh Amoozgar¹, Mehdi Jaymand², Rana Jahanban-Esfahlan³

Affiliations

¹ Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
² Nano Drug Delivery Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
³ Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.

No abstract available

Keywords: cancer metastasis; cell-free DNA; circulating tumor cells (CTCs); exosomes; liquid biopsy; tumor biomarkers.

Publication types

Editorial